Pivotal-Point Tracking Envista Holdings (NVST): Global Player in Dentistry Increases Q4 Revenue to $751 Million Through AI Diagnostics!
Reading Time: 1 minute
Envista Holdings is a provider of dental products, consolidating over 30 brands such as Nobel Biocare and Ormco. On February 6th, the stock experienced a surge after the company reported excellent quarterly results the night before. With a revenue of $751 million and an adjusted earnings per share of $0.38, the market expectations were significantly exceeded. Particularly, the Specialty Products & Technologies segment demonstrated double-digit growth. The company returned to profitability in 2025 and is instilling confidence in its recovery...
Read this article now with a free account.
Your benefits:
- Every month, you can read 5 articles from the premium section for free.
- Monthly 2 trial issues of the Trader newspaper for free.
- Create a personal watchlist with an overview of news about your stock.

